FDA panel to vote on Johnson & Johnson booster

An FDA panel is expected to decide whether to recommend a Johnson & Johnson booster shot of its COVID-19 vaccine.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting